Nuvalent Inc vs Vistra Corp — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Vistra Corp trades at $162.61 (market cap $53.27B). The key difference: Vistra Corp is far larger — about 5.4× Nuvalent Inc's market cap, and Vistra Corp pays a 0.58% dividend while Nuvalent Inc pays none. Which is the better fit depends on your goals.
| NUVL | VST | |
|---|---|---|
Market Cap | $9.81B | $53.27B |
Sector | Technology | Technology |
52-Week High | $123.96 | $217.92 |
52-Week Low | $72.16 | $134.71 |
Enterprise Value | $8.52B | $75.03B |
Dividend Yield | — | 0.58% |
Trailing returns across standard periods
Latest headlines on both assets
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.
Read more on VST →